Trial intelligence / Profile preview

Ferumoxytol-enhanced Imaging in neuroAIDS

NCT02678767Phase 2Completed

Sponsor
Beau Nakamoto
Start
Feb 2015
Primary completion
Sep 2017
Modality
Nanoparticles, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ferumoxytol in HIV-associated neurocognitive disorder (HAND), sponsored by Beau Nakamoto. Started Feb 2015; status: completed.

02

Drugs

ferumoxytol
03

Conditions

HIV-associated neurocognitive disorder (HAND)

Beyond the preview

Go deeper on NCT02678767.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02678767.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call